United Therapeutics | UTHR - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Amarin USD 51.48M 113K 2025-12
Ardelyx USD 133.3M 6.04M 2026-06
Baxter International USD 6.5B 3.82B 2026-09
Bayer EUR 9.92B 121M 2026-09
BioCryst Pharmaceuticals USD -397.38M 517.17M 2026-09
Biogen USD 2.32B 663.6M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
Halozyme Therapeutics USD 198M 4.66M 2026-09
Insmed USD 606.26M 79.46M 2026-09
Ionis Pharmaceuticals USD 373M 2.76M 2026-09
J&J USD 18.93B 1.09B 2026-09
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Moderna USD 1.18B 223M 2026-09
Omeros USD 59.16M 20.13M 2024-06
Pfizer USD 89B 3.81B 2026-09
PTC Therapeutics USD 211.54M 15.12M 2026-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
Teva Pharmaceutical Industries USD 3.18B 733M 2026-09
United Therapeutics USD 6.28B 124.3M 2026-09
Vertex Pharmaceuticals USD 2.18B 118.2M 2026-09